Mesoblast shares rose 5.5% in recent Friday trading, a day after the company reported Q4 gross revenue from its cell therapy Ryoncil rose 60% to $35.1 million from Q3. Ryoncil is the only...
Mesoblast Shares Rise After Ryoncil Sales Jump in Q4
Mesoblast shares rose 5.5% in recent Friday trading, a day after the company reported Q4 gross revenue from its cell therapy Ryoncil rose 60% to $35.1 million from Q3. Ryoncil is the only...
